<!DOCTYPE html>
<!--[if IE 7]>                  <html class="ie7 no-js" lang="en" dir="ltr"
  xmlns:og="http://ogp.me/ns#"
  xmlns:article="http://ogp.me/ns/article#"
  xmlns:book="http://ogp.me/ns/book#"
  xmlns:profile="http://ogp.me/ns/profile#"
  xmlns:video="http://ogp.me/ns/video#"
  xmlns:product="http://ogp.me/ns/product#">     <![endif]-->
<!--[if lte IE 8]>              <html class="ie8 no-js" lang="en" dir="ltr"
  xmlns:og="http://ogp.me/ns#"
  xmlns:article="http://ogp.me/ns/article#"
  xmlns:book="http://ogp.me/ns/book#"
  xmlns:profile="http://ogp.me/ns/profile#"
  xmlns:video="http://ogp.me/ns/video#"
  xmlns:product="http://ogp.me/ns/product#">     <![endif]-->
<!--[if (gte IE 9)|!(IE)]><!--> <html class="not-ie no-js" lang="en" dir="ltr"
  xmlns:og="http://ogp.me/ns#"
  xmlns:article="http://ogp.me/ns/article#"
  xmlns:book="http://ogp.me/ns/book#"
  xmlns:profile="http://ogp.me/ns/profile#"
  xmlns:video="http://ogp.me/ns/video#"
  xmlns:product="http://ogp.me/ns/product#">  <!--<![endif]-->
<head>
  <!--[if IE]><![endif]-->
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<link rel="shortcut icon" href="../sites/default/files/Favicon2.png" type="image/png" />
<meta name="description" content="U.S. Department of Health and Human Services Medication Use in Long-Term Care Facilities and Community Settings for Medicare Beneficiaries with Cardiovascular Disease Becky Briesacher, Jalpa Doshi, Bruce Stuart and Ilene Zuckerman University of Maryland December 18, 2002 PDF Version: http://aspe.hhs.gov/daltcp/reports/2002/cdmeduse.pdf (19 PDF pages)" />
<meta name="generator" content="Drupal 7 (http://drupal.org)" />
<link rel="canonical" href="medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease.html" />
<link rel="shortlink" href="https://aspe.hhs.gov/node/66246" />
<meta property="og:site_name" content="ASPE" />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://aspe.hhs.gov/basic-report/medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease" />
<meta property="og:title" content="Medication Use in Long-Term Care Facilities and Community Settings for Medicare Beneficiaries with Cardiovascular Disease" />
<meta property="og:description" content="U.S. Department of Health and Human Services Medication Use in Long-Term Care Facilities and Community Settings for Medicare Beneficiaries with Cardiovascular Disease Becky Briesacher, Jalpa Doshi, Bruce Stuart and Ilene Zuckerman University of Maryland December 18, 2002 PDF Version: http://aspe.hhs.gov/daltcp/reports/2002/cdmeduse.pdf (19 PDF pages)" />
<meta property="og:updated_time" content="2017-02-21T11:35:07-05:00" />
<meta property="article:published_time" content="2015-12-09T05:20:47-05:00" />
<meta property="article:modified_time" content="2017-02-21T11:35:07-05:00" />

  <title>Medication Use in Long-Term Care Facilities and Community Settings for Medicare Beneficiaries with Cardiovascular Disease | ASPE</title>
	<meta http-equiv="X-UA-Compatible" content="IE=edge"><script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function(e,n,t){function r(t){if(!n[t]){var o=n[t]={exports:{}};e[t][0].call(o.exports,function(n){var o=e[t][1][n];return r(o||n)},o,o.exports)}return n[t].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<t.length;o++)r(t[o]);return r}({1:[function(e,n,t){function r(){}function o(e,n,t){return function(){return i(e,[c.now()].concat(u(arguments)),n?null:this,t),n?void 0:this}}var i=e("handle"),a=e(2),u=e(3),f=e("ee").get("tracer"),c=e("loader"),s=NREUM;"undefined"==typeof window.newrelic&&(newrelic=s);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],d="api-",l=d+"ixn-";a(p,function(e,n){s[n]=o(d+n,!0,"api")}),s.addPageAction=o(d+"addPageAction",!0),s.setCurrentRouteName=o(d+"routeName",!0),n.exports=newrelic,s.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(e,n){var t={},r=this,o="function"==typeof n;return i(l+"tracer",[c.now(),e,t],r),function(){if(f.emit((o?"":"no-")+"fn-start",[c.now(),r,o],t),o)try{return n.apply(this,arguments)}finally{f.emit("fn-end",[c.now()],t)}}}};a("setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(e,n){m[n]=o(l+n)}),newrelic.noticeError=function(e){"string"==typeof e&&(e=new Error(e)),i("err",[e,c.now()])}},{}],2:[function(e,n,t){function r(e,n){var t=[],r="",i=0;for(r in e)o.call(e,r)&&(t[i]=n(r,e[r]),i+=1);return t}var o=Object.prototype.hasOwnProperty;n.exports=r},{}],3:[function(e,n,t){function r(e,n,t){n||(n=0),"undefined"==typeof t&&(t=e?e.length:0);for(var r=-1,o=t-n||0,i=Array(o<0?0:o);++r<o;)i[r]=e[n+r];return i}n.exports=r},{}],4:[function(e,n,t){n.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(e,n,t){function r(){}function o(e){function n(e){return e&&e instanceof r?e:e?f(e,u,i):i()}function t(t,r,o,i){if(!d.aborted||i){e&&e(t,r,o);for(var a=n(o),u=m(t),f=u.length,c=0;c<f;c++)u[c].apply(a,r);var p=s[y[t]];return p&&p.push([b,t,r,a]),a}}function l(e,n){v[e]=m(e).concat(n)}function m(e){return v[e]||[]}function w(e){return p[e]=p[e]||o(t)}function g(e,n){c(e,function(e,t){n=n||"feature",y[t]=n,n in s||(s[n]=[])})}var v={},y={},b={on:l,emit:t,get:w,listeners:m,context:n,buffer:g,abort:a,aborted:!1};return b}function i(){return new r}function a(){(s.api||s.feature)&&(d.aborted=!0,s=d.backlog={})}var u="nr@context",f=e("gos"),c=e(2),s={},p={},d=n.exports=o();d.backlog=s},{}],gos:[function(e,n,t){function r(e,n,t){if(o.call(e,n))return e[n];var r=t();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,n,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return e[n]=r,r}var o=Object.prototype.hasOwnProperty;n.exports=r},{}],handle:[function(e,n,t){function r(e,n,t,r){o.buffer([e],r),o.emit(e,n,t)}var o=e("ee").get("handle");n.exports=r,r.ee=o},{}],id:[function(e,n,t){function r(e){var n=typeof e;return!e||"object"!==n&&"function"!==n?-1:e===window?0:a(e,i,function(){return o++})}var o=1,i="nr@id",a=e("gos");n.exports=r},{}],loader:[function(e,n,t){function r(){if(!x++){var e=h.info=NREUM.info,n=d.getElementsByTagName("script")[0];if(setTimeout(s.abort,3e4),!(e&&e.licenseKey&&e.applicationID&&n))return s.abort();c(y,function(n,t){e[n]||(e[n]=t)}),f("mark",["onload",a()+h.offset],null,"api");var t=d.createElement("script");t.src="https://"+e.agent,n.parentNode.insertBefore(t,n)}}function o(){"complete"===d.readyState&&i()}function i(){f("mark",["domContent",a()+h.offset],null,"api")}function a(){return E.exists&&performance.now?Math.round(performance.now()):(u=Math.max((new Date).getTime(),u))-h.offset}var u=(new Date).getTime(),f=e("handle"),c=e(2),s=e("ee"),p=window,d=p.document,l="addEventListener",m="attachEvent",w=p.XMLHttpRequest,g=w&&w.prototype;NREUM.o={ST:setTimeout,CT:clearTimeout,XHR:w,REQ:p.Request,EV:p.Event,PR:p.Promise,MO:p.MutationObserver};var v=""+location,y={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-1026.min.js"},b=w&&g&&g[l]&&!/CriOS/.test(navigator.userAgent),h=n.exports={offset:u,now:a,origin:v,features:{},xhrWrappable:b};e(1),d[l]?(d[l]("DOMContentLoaded",i,!1),p[l]("load",r,!1)):(d[m]("onreadystatechange",o),p[m]("onload",r)),f("mark",["firstbyte",u],null,"api");var x=0,E=e(4)},{}]},{},["loader"]);</script>

	<!-- Mobile Specific Metas
	================================================== -->
	<meta name="viewport" content="width=device-width,initial-scale=1.0,maximum-scale=1.0,user-scalable=0">

  <link type="text/css" rel="stylesheet" href="../sites/default/files/advagg_css/css__5ln8neBOcJfyUveiD4y9fhI6kHBLOQ_YL0mMC-LS9a0__TPJIZT9UBnf_685NlFTJ5KnZVsjwFk6ACQ-nwwygmwU__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.css" media="all" />
<link type="text/css" rel="stylesheet" href="../sites/default/files/advagg_css/css__ng49uRH5y4Hl9VF9hHW_vXOj-mcOc2u2ShJqJ1YKIGU__FoMCD14GBvZaRiqSQ_JpP1w3rDB21n7H2Ar4pRZaIh8__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.css" media="all" />
<link type="text/css" rel="stylesheet" href="../sites/default/files/advagg_css/css__Hskudx14OJ5Hz8vqU7CUgN6SDV5rINZuEq9VuGsSeyc__EwNIl3xeFrniW2TmonovTzhSs3X5MdFps210puE7jog__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.css" media="all" />
<link type="text/css" rel="stylesheet" href="../sites/default/files/advagg_css/css__9rZoaX9BdzjjNucvYxduxeNAVO2zgW_Rvjhb5rq5whc__lSr_y16grDSgHf4booPChnF7QXz3TQY3hafH49twE0k__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.css" media="all" />
<link type="text/css" rel="stylesheet" href="../sites/default/files/advagg_css/css__ZgfI_ZPib5yVY0o5aKo_6TFn946Tuu_nFDa0ySTmkSc__2FTFrNw2eNh0mpHIOA34r6YRwBZMm2PjJ_JubnwLigg__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.css" media="all" />
<link type="text/css" rel="stylesheet" href="../sites/default/files/advagg_css/css__dxabpJ5rQgDSixKgLJZjWc1beC6mpROKwVrmWxI5eno__rqhz_hGsE_i59O7-W991o71_Jxw1QOtGMxn4nsOLHY8__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.css" media="all" />
<link type="text/css" rel="stylesheet" href="../sites/default/files/advagg_css/css__ZbRCq2NqWgK-HXAQI3So0N1n0nr4HonsJS3eQuuxukw__7Olkk8Locn8Dj0eR0Ww3rbV9lks9sxipcboMXB18RRs__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.css" media="all" />

	<!-- Head Libs -->
	<script src="../sites/all/themes/stability/stability_aspe/vendor/modernizr.js"></script>

	<!--[if lt IE 9]>
		<script src="http://html5shim.googlecode.com/svn/trunk/html5.js"></script>
		<script src="/sites/all/themes/stability/vendor/respond.min.js"></script>
	<![endif]-->

	<!-- Favicons
	================================================== -->
	<link rel="apple-touch-icon" href="../sites/all/themes/stability/images/apple-touch-icon.png">
	<link rel="apple-touch-icon" sizes="72x72" href="../sites/all/themes/stability/images/apple-touch-icon-72x72.png">
	<link rel="apple-touch-icon" sizes="114x114" href="../sites/all/themes/stability/images/apple-touch-icon-114x114.png">
	<link rel="apple-touch-icon" sizes="144x144" href="../sites/all/themes/stability/images/apple-touch-icon-144x144.png">

</head>
<body class="html not-front not-logged-in no-sidebars page-node page-node- page-node-66246 node-type-basic-report">
<!-- Google Tag Manager -->
<noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-JLFR"
                  height="0" width="0" style="display:none;visibility:hidden" title="googletagmanager"></iframe></noscript>
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
    new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
    j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
    '//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
  })(window,document,'script','dataLayer','GTM-JLFR');</script>
<!-- End Google Tag Manager -->
  <div id="skip-nav" class="accessibility_menu">
    <strong>Shortcut Navigation:</strong>
    <ul>
      <li><a href="medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease.html#content" accesskey="c" title="Skip to page content (ctrl/alt + c)">Page Content</a></li>
      <li><a href="medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease.html#nav" accesskey="m" title="Skip to main navigation menu (ctrl/alt + m)">Site Navigation</a></li>

      <li><a href="medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease.html#Footer" accesskey="f" title="Skip to footer (ctrl/alt + f)">Footer</a></li>
    </ul>
  </div>

    
<div class="site-wrapper">
  
  <header class="header header-menu-fullw header-top-clean">
    <div id="brand-bar">
        <div class="container">
                    <img alt='bird' src="../sites/all/themes/stability/stability_aspe/images/bird.png"> <a target="blank" tabindex="4" href="http://www.hhs.gov/">U.S. Department of Health & Human Services</a>
        </div>

    </div>
    <div class="header-main">
        <div class="container clearfix">
            <div class="social-links-wrapper">
                <ul class="social-links social-links__light">
                                                          <li><a href="http://twitter.com/hhs_aspe"><img alt="twitter" src="../sites/all/themes/stability/stability_aspe/images/tw.png"/></a></li>
                                    <!--                  --><!--                    <li><a href="http://--><!--"><img alt="linkedin" src="--><!--/images/linkedin.png"/></a></li>-->
<!--                  -->
                                                                      </ul>
            </div>
            <!-- Logo -->
            <div class="logo">
                                <div class="site_name_wrapper">
                                     <span class="h1">
                                      <a href="../images/exit_disclaimer.jpg.html">ASPE</a>
                                       </span>
                                  <p class="tagline"><p>Office of The Assistant Secretary</p><p> for Planning and Evaluation</p></p>
                    </div>
            </div>
            <!-- Logo / End -->
            <div class="header_right_wrapper">
                <div class="search-form">
                    <form action="medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease.html" method="post" id="search-block-form" accept-charset="UTF-8"><div><div class="container-inline">
  <div class = "input-group"><div class="form-type-textfield form-item-search-block-form form-item form-group">
  <label class="element-invisible" for="edit-search-block-form--2">Search </label>
 <input title="Enter the terms you wish to search for." placeholder="Search Site..." class="form-control form-control form-text" type="text" id="edit-search-block-form--2" name="search_block_form" value="" size="15" maxlength="128" />
</div>
<div class="form-actions form-wrapper" id="edit-actions--2"><input class="btn btn-primary btn-icon form-submit" type="image" id="edit-submit" name="submit" value="Search" src="../sites/all/themes/stability/stability_aspe/images/search-white2.png" alt="Search" title="Search" /></div></div><input type="hidden" name="form_build_id" value="form-S-xp8jJ6PPlyJIPbK6Xehklb4yCZuklSf35ShdftW4Y" />
<input type="hidden" name="form_id" value="search_block_form" />
</div>
</div></form>                </div>
                <button type="button" class="navbar-toggle" value="Menu">
                    <i class="fa fa-bars"></i>Menu
                </button>
            </div>

        </div>
    </div>

    <!-- Navigation -->
    <nav id="nav" class="nav-main">
        <div class="container">
          <ul data-breakpoint="767" class="flexnav">
                <li class="first expanded"><a href="../basic-search/about.html" title="">About</a><ul><li class="first leaf"><a href="../node/41366.html" title="">Mission</a></li>
<li class="leaf"><a href="../key-staff.html" title="">Leadership</a></li>
<li class="leaf"><a href="https://www.usajobs.gov/" title="">Careers</a></li>
<li class="expanded"><a href="../node/83081.html" title="linkTo">Coordination</a><ul><li class="first leaf"><a href="../node/94561.html" title="">Evaluation &amp; Evidence</a></li>
<li class="leaf"><a href="../node/83126.html">National Alzheimer&#039;s Project Act</a></li>
<li class="leaf"><a href="../hhs-data-council.html">HHS Data Council</a></li>
<li class="last leaf"><a href="../node/83076.html" title="National Council on Vital and Health Statistics">National Council on Vital and Health Statistics</a></li>
</ul></li>
<li class="expanded"><a href="../basic-search/divisions.html" title="">Offices</a><ul><li class="first leaf"><a href="../daltcp/home.htm">Disability, Aging, and Long-Term Care Policy</a></li>
<li class="leaf"><a href="../node/57001.html">Health Policy</a></li>
<li class="leaf"><a href="../hsp/index.shtml.html">Human Services Policy</a></li>
<li class="last leaf"><a href="../node/57011.html">Science and Data Policy</a></li>
</ul></li>
<li class="leaf"><a href="../node/83096.html" title="Strategic Planning">Strategic Planning</a></li>
<li class="last leaf"><a href="../node/83911.html" title="">Contact ASPE</a></li>
</ul></li>
<li class="expanded"><a href="../basic-search/topics.html" title="">Topics</a><ul><li class="first leaf"><a href="../health/reports/2012/ACA-Research/index.cfm.html">Affordable Care Act Research</a></li>
<li class="leaf"><a href="../node/101296.html">Alzheimer&#039;s / Dementia</a></li>
<li class="leaf"><a href="../node/105551.html">Early Childhood</a></li>
<li class="leaf"><a href="../node/103281.html">Incarceration &amp; Reentry</a></li>
<li class="leaf"><a href="../node/83056.html" title="Opioids">Opioids</a></li>
<li class="leaf"><a href="../node/83296.html">Patient-Centered Outcomes Research Trust Fund (PCORTF)</a></li>
<li class="expanded"><a href="../basic-search/poverty.html" title="">Poverty</a><ul><li class="first leaf"><a href="../node/107166.html">Poverty Guidelines</a></li>
<li class="last leaf"><a href="../node/107171.html">Poverty Analysis</a></li>
</ul></li>
<li class="leaf"><a href="../node/164501.html">Teen Pregnancy Prevention</a></li>
<li class="leaf"><a href="../node/100556.html">Homelessness</a></li>
<li class="last leaf"><a href="../node/117441.html">MACRA</a></li>
</ul></li>
<li class="leaf"><a href="../reports.html" title="">Publications</a></li>
<li class="last expanded"><a href="../basic-search/datasets.html" title="">Data and Tools</a><ul><li class="first last leaf"><a href="../pic/index.cfm.html" title="">Evaluation Database</a></li>
</ul></li>
            </ul>
        </div>
    </nav>
    <!-- Navigation / End -->
</header>  <div class="main" role="main">
    <!--PAGEWATCH CODE="USHHS_458"-->
    <section class="page-heading">
  <div class="container">
    <div class="row">

        <div class="col-md-6">
                <h1>
                    
          Medication Use in Long-Term Care Facilities and Community Settings for Medicare Beneficiaries with Cardiovascular Disease        </h1>
                                 <p class="author">
                                                 <span class="date-display-single" property="dc:date" datatype="xsd:dateTime" content="2002-12-18T00:00:00-05:00">12/18/2002</span>               
                           </p>


                  </div>


        <div class="col-md-6">
           <ul class="breadcrumb"><li class="first"><a href="../images/exit_disclaimer.jpg.html" title="Home">Home</a></li>
<li class="last">Medication Use in Long-Term Ca...</li>
</ul>        </div>


    </div>
  </div>
</section>
    
      <div  class="nd-region nd-region-filter">
  
       

    
      <div  id="Filter" class="row">     

        
                  
        
                  
        
                  
        
                  
        
                  
        
                  
        
                  
        
                  
        
      </div>

    
    
      </div>
    


      <div  class="nd-region nd-region-similar-content">
  
       

    
      <div  id="Similar-Content" class="row">     

        
                  
        
                                    <div  id="top" class="">
                          
                              <div id="block-views-2100ccfdd214bdbcf634d7e4832c265b" class="widget block block-views solr-similar-content" >
  
        <div class="title-accent">
			<h3 class = "widget-title" ><span>Similar</span> content</h3>
		</div>
    
  <div class="view view-similar-content-solr view-id-similar_content_solr view-display-id-block_solr_similar_content view-dom-id-8f141c4c5e13a28564f2db756f9324d2">
        
  
  
      
    
    <span class="field-content"><a href="https://aspe.hhs.gov/pdf-report/medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease">Medication Use in Long-Term Care Facilities and Community Settings for Medicare Beneficiaries with Cardiovascular Disease</a></span>    
    <span class="field-content"><a href="medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities.html">Medication Use by Medicare Beneficiaries Living in Nursing Homes and Assisted Living Facilities</a></span>    
    <span class="field-content"><a href="https://aspe.hhs.gov/basic-report/national-comparison-prescription-drug-expenditures-medicare-beneficiaries-living-community-and-long-term-care-facility-settings">A National Comparison of Prescription Drug Expenditures by Medicare Beneficiaries Living in the Community and Long-Term Care Facility Settings</a></span>    
    <span class="field-content"><a href="national-estimates-prescription-drug-utilization-and-expenditures-long-term-care-facilities.html">National Estimates of Prescription Drug Utilization and Expenditures in Long-Term Care Facilities</a></span>    
    <span class="field-content"><a href="../execsum/prescription-drug-spending-medicare-beneficiaries-institutional-and-residential-settings-1998-2001.html">Prescription Drug Spending by Medicare Beneficiaries in Institutional and Residential Settings, 1998-2001</a></span>  
  
  
  
  
  
</div>
  </div> <!-- /.block -->
              
                          </div>
                              
        
                  
        
                  
        
                  
        
                  
        
                  
        
                  
        
      </div>

    
    
      </div>
    


      <div  class="nd-region">
  
       

          <div class = "container">
    
      <div  class="row" id="Content">     

        
                  
        
                  
        
                  
        
                                    <div  class="col-md-12 " id="content">
                          
                              <div id="block-aspe-aspe-addthis" class="widget block block-aspe" >
  
      
  <div class="clearfix">
  <ul class="addthis_sharing_toolbox node-share__links" data-url="https://aspe.hhs.gov/basic-report/medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease" data-title="Medication Use in Long-Term Care Facilities and Community Settings for Medicare Beneficiaries with Cardiovascular Disease">
    <li><a class="addthis_button_print"><img src="../sites/all/themes/stability/stability_aspe/images/print-white.png" alt="print" /></a></li>
    <li><a class="addthis_button_email"><img src="../sites/all/themes/stability/stability_aspe/images/mail-white.png" alt="email" /></a></li>
    <li><a class="addthis_button_twitter"><img src="../sites/all/themes/stability/stability_aspe/images/tw.png" alt="twitter" /></a></li>
<!--    <li><a class="addthis_button_facebook">--><!--</a></li>-->
    <li><a class="addthis_button_compact"><img src="../sites/all/themes/stability/stability_aspe/images/plus-white.png" alt="compact" /></a></li>
  </ul>
</div>

  </div> <!-- /.block -->

                
    
  
  <div class="content clearfix node-basic-report">
    <p><font><b><font face="Calisto MT">U.S. Department of Health and Human Services</font></b></font></p>
<h1>Medication Use in Long-Term Care Facilities and  		Community Settings for Medicare Beneficiaries with Cardiovascular Disease</h1>
<h3>Becky Briesacher, Jalpa Doshi, Bruce Stuart and Ilene Zuckerman</h3>
<h3>University of Maryland</h3>
<h3>December 18, 2002</h3>
<p>PDF Version:  		<a href="../system/files/pdf/73251/cdmeduse.pdf">http://aspe.hhs.gov/daltcp/reports/2002/cdmeduse.pdf</a>  		(19 PDF pages)</p>
<hr /><blockquote>
<p><i>This report was prepared under contract #HHS-100-01-0023 between  		  the U.S. Department of Health and Human Services (HHS), Office of Disability,  		  Aging and Long-Term Care Policy (DALTCP) and the University of Maryland. For  		  additional information about this subject, you can visit the DALTCP home page  		  at <a href="../_/office_specific/daltcp.cfm.html">http://aspe.hhs.gov/_/office_specific/daltcp.cfm</a> or contact the office at  		  HHS/ASPE/DALTCP, Room 424E, H.H. Humphrey Building, 200 Independence Avenue,  		  S.W., Washington, D.C. 20201. The e-mail address is: <a href="mailto:webmaster.DALTCP@hhs.gov">webmaster.DALTCP@hhs.gov</a>.  		  The Project Officer was Andreas Frank.</i></p>
<p><i>The opinions and views expressed in this report are those of the  		  authors. They do not necessarily reflect the views of the Department of Health  		  and Human Services, the contractor or any other funding organization.</i></p>
</blockquote>
<hr /><h2>TABLE OF CONTENTS</h2>
<dl><dt><a href="medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease.html#abs">ABSTRACT</a></dt>
</dl><dl><dt><a href="medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease.html#study">STUDY OBJECTIVES</a></dt>
</dl><dl><dt><a href="medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease.html#method">METHODS</a></dt>
</dl><dl><dt><a href="medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease.html#result">RESULTS</a></dt>
</dl><dl><dt><a href="medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease.html#discuss">DISCUSSION</a></dt>
</dl><dl><dt><a href="medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease.html#append">APPENDIX</a></dt>
</dl><dl><dt>LIST OF TABLES</dt>
<dd><a href="medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease.html#table1">TABLE 1</a>. Medicare Beneficiaries with  		  Cardiovascular Disease by Living Situation, 1998 </dd>
<dd><a href="medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease.html#table2">TABLE 2</a>. Characteristics of Medicare  		  Beneficiaries with Cardiovascular Disease by Living Situation, 1998 </dd>
<dd><a href="medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease.html#table3">TABLE 3</a>. Health and Functional Status of  		  Medicare Beneficiaries with Cardiovascular Conditions by Living Situation, 1998  		  </dd>
<dd><a href="medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease.html#table4">TABLE 4</a>. Prevalence of Cardiovascular  		  Medication Use by Medicare Beneficiaries with Cardiovascular Disease by Living  		  Situation, 1998 </dd>
<dd><a href="medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease.html#table5">TABLE 5</a>. Prevalence of Non-Cardiovascular  		  Medication Use by Medicare Beneficiaries with Cardiovascular Diseases by Living  		  Situation, 1998 </dd>
<dd><a href="medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease.html#tableA1">TABLE A1</a>. Unweighted Sample Sizes Based on  		  Claims Data</dd>
<dd><a href="medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease.html#tableA2">TABLE A2</a>. Distribution of Sample by the Number  		  of Cardiovascular- Related Claims in 1998 </dd>
</dl><h2><a name="abs" id="abs">ABSTRACT</a></h2>
<h3>Objectives</h3>
<p>This report compares medication use in long-term care facilities and  		community settings for Medicare beneficiaries with heart conditions. The  		purpose of this comparison was to evaluate the utility of a new file of  		institutional drug use in the Medicare Current Beneficiary Survey (MCBS), the  		premier source of health care information on the Medicare population.  		Descriptions of medication use include the prevalence of drugs from 12  		cardiovascular drug classes and 28 other major therapeutic drug categories.  		Characteristics of beneficiaries include type of heart disease, co-morbidities,  		functional levels and health status, demographics, Medicare supplemental  		coverage, and regional residence.</p>
<h3>Methods</h3>
<p> Data are from the 1998 MCBS public use files merged with a new dataset  		of drug administrations for the survey's facility sample. The MCBS captures a  		comprehensive picture of the health status, health care use, health insurance  		coverage, and socioeconomic and demographic characteristics of Medicare  		beneficiaries residing in the community or institutions (nursing homes and  		assisted living and related facilities). The institutional drug administration  		file contains medical record abstracts of medications prescribed and  		administered to residents while institutionalized. The study sample comprises  		821 institutionalized beneficiaries and 5,692 community-dwelling beneficiaries  		with Medicare Part A or Part B claims indicating cardiovascular-related  		diagnoses. Estimates are weighted to reflect the drug use patterns of the  		Medicare population with heart disease.</p>
<h3>Results</h3>
<p>In 1998, approximately 58% (17.6 million) of the community-dwelling  		Medicare population and 75% (1.7 million) of the institutionalized Medicare  		population were treated for cardiovascular conditions. Use of certain heart  		medications was similar across the two populations, although facility residents  		were less likely to use other classes of heart drugs. Among beneficiaries  		treated for heart disease, nearly all (80%) used some type of cardiovascular  		drug therapy during the year, regardless of residential setting. Diuretics were  		the most commonly prescribed category of heart medications for both groups (50%  		of institutional residents vs. 40% of community residents). Use of  		angiotensin-converting enzyme (ACE) inhibitors--the second most common heart  		medicine--was also similar (27% of institutional residents vs. 25% of community  		residents). Large differences were noted in the prescribing of the following  		categories of drugs: institutionalized beneficiaries with heart disease were  		three times <i>less likely </i>to be prescribed cholesterol-lowering agents (6%  		vs. 19%) as those treated in the community setting, two times <i>less  		likely</i> to take beta-blockers (12% vs. 24%), and one-third <i>less  		likely</i> to take calcium channel blockers (22% vs. 30%). Institutionalized  		beneficiaries were <i>more likely</i> than community beneficiaries to use  		digitalis (24% vs. 14%). These differences can be explained, in part, by the  		dissimilarities in the cardiovascular conditions suffered by the two population  		groups. Facility-dwelling beneficiaries tended to exhibit more advanced forms  		of heart disease than their counterparts in the community, and they often had  		co-existing illnesses that can complicate the selection of cardiovascular  		agents. Almost 70% of all cardiovascular treatment in the institutional setting  		was for heart failure, cardiomyopathy or other complications of heart disease  		compared to 45% in the community. About 25% of the institutional population had  		artherosclerosis compared to 8% in the community. Institutionalized residents  		with heart disease more often suffer from concomitant illnesses such as mental  		disorders (70%), cerebrovascular disease (37%), and diabetes (30%). In  		contrast, less than 25% of community-dwelling beneficiaries with heart disease  		had evidence of any of these chronic conditions.</p>
<h3>Conclusions</h3>
<p> These national estimates of cardiovascular drug use in Medicare  		beneficiaries with heart disease serve as the first comparison in a consistent  		dataset of prescribing patterns across long-term care and community settings.  		The comparison showed that medication use and disease burden varied greatly for  		beneficiaries depending on residence. These differences are important when  		evaluating population-level patterns of care because prescribers must assess  		both the type of heart disease and the potential for interaction with  		concomitant conditions or therapies when selecting cardiovascular agents.  		Nevertheless, the lower use of some heart medicines in the institutional  		setting was notable given the overall severity of cardiovascular disease in  		this population. Since facility residents tended to use more medications than  		community residents in 27 of 28 other major drug categories, the lower use of  		some types of heart medicines (especially those used in secondary prevention)  		is anomalous. Future research should assess the possibility of under-treatment  		of cardiovascular disease in institutional settings.</p>
<h2><a name="study" id="study">STUDY OBJECTIVES</a></h2>
<p>This study compares drug use in the community settings and long-term  		care facilities for Medicare beneficiaries with heart conditions. The purpose  		of this comparison was to evaluate the utility of a new file of institutional  		drug use in the MCBS, the premier source of health care information on the  		Medicare population. This analysis focused on beneficiaries with cardiovascular  		disease,because heart conditions are commonly treated in both settings and  		heart medicines encompass a wide variety of therapeutic choices. Our two main  		research aims are:</p>
<ol><li>
<p><b>To characterize beneficiaries with cardiovascular diseases by  			 residence</b>: How do Medicare beneficiaries with cardiovascular disease differ  			 by residence in the community or long-term care facilities? To what extent do  			 they share similarities in type of heart disease, demographic characteristics,  			 health care coverage, health status and co-morbidities?</p>
</li>
<li>
<p><b>To characterize the prevalence of cardiovascular drug use for  			 beneficiaries by residence</b>: How do pharmacologic treatments differ for  			 beneficiaries with cardiovascular disease between the two settings? Do Medicare  			 beneficiaries use different types of cardiovascular medications depending on  			 the site of residence?</p>
</li>
</ol><h2><a name="method" id="method">METHODS</a></h2>
<p>This study used the 1998 MCBS Cost and Use files merged with an  		institutional drug administration file for the survey's facility sample. The  		institutional drug administration file fills an important gap in our  		understanding of the medical care administered to beneficiaries living in  		facilities, and it provides the first opportunity for a cross-setting  		comparison of national drug use patterns for Medicare beneficiaries. The study  		sample consisted of all community-dwelling and institutional beneficiaries with  		at least one diagnosis of cardiovascular disease in their Part A or Part B  		Medicare claims (inpatient or outpatient care). (See Appendix  		<a href="medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease.html#tableA1">Tables A1</a> and <a href="medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease.html#tableA2">Table A2</a> for  		details on sample selection). Beneficiaries were classified as  		community-dwelling or institutionalized according to the living situation codes  		in the MCBS. MCBS sample persons are drawn from Medicare enrollment records  		without regard for their residential status. MCBS interviewers locate sample  		persons and if they are living in institutions with at least three long-term  		care beds and offering specified services they are assigned a facility  		residence. It should be noted that while the MCBS facility sample is  		representative of the Medicare population that lives in long-term care  		facilities, it is not representative of the universe of all residents of  		long-term care facilities. Institutionalized beneficiaries include residents of  		licensed nursing homes, assisted living or related facilities, and mental  		health or retardation facilities. For this analysis, we assigned beneficiaries  		with multiple living situations to institutional status because prescription  		drug data were captured more completely during the facility stay. Information  		on beneficiary characteristics (demographics, income, geographic residence,  		supplemental insurance, general health status and functional status) came from  		the MCBS survey. Type of heart disease and prevalence of other chronic  		conditions were drawn from the diagnostic fields in Medicare Part A and Part B  		claims.</p>
<p>Information on drug use came from the MCBS's institutional drug  		administration file for facility residents and the MCBS's prescribed medicine  		event file for community residents. The prescribed medicine event file contains  		self-reports of prescriptions filled and refilled during the year  		(over-the-counter medication use is not captured). MCBS respondents living in  		the community are asked to present all prescription drug containers and saved  		insurance receipts at each interview round as well as to keep a medication log  		for the entire year. The institutional drug administration file contains  		monthly record abstracts of all medications prescribed and administered to  		residents during their institutional stay. This file includes drugs never  		administered and medicines designated as over-the-counter drugs in the  		community setting since all drugs are prescribed in the facility setting. In  		our analysis, we excluded both drugs not administered and prescribed  		over-the-counter, such as aspirin.</p>
<p> All results were weighted to be nationally representative. Estimates  		failing reliability thresholds of at least 20 sample persons per analytic cell  		are noted.</p>
<h2><a name="result" id="result">RESULTS</a></h2>
<p><i>Prevalence of heart disease.</i> <a href="medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease.html#table1">Table 1</a> shows  		the prevalence of heart disease in the study population by living situation. In  		1998, approximately 58% (17.6 million) of the community-dwelling Medicare  		population and 76% (1.7 million) of the institutionalized Medicare population  		were treated for cardiovascular-related conditions.</p>
<p><i>Beneficiary characteristics.</i> <a href="medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease.html#table2">Table 2</a> shows  		that although both populations share cardiovascular disease they differ  		substantively across many other characteristics. The institutional group is  		much older than the community-dwelling group (over 50% are at least age 85 vs.  		12%), and they are more often female (71% institutional vs. 57%  		community-dwelling). Nearly 60% of institutional beneficiaries with heart  		conditions have annual incomes of $10,000 or less, compared to about 40% of  		those in the community. Among beneficiaries with heart disease, those in  		institutions more often live in the Midwestern part of the United States than  		those in the community (34% vs. 24%) and less often in the South (33% vs. 39%).  		Medicare supplemental coverage is vastly different in the two settings. Only  		one-third of all institutionalized beneficiaries with heart disease have  		private forms of health insurance (e.g, Medigap or employer-sponsored benefits)  		and they instead rely heavily upon Medicaid (61%). In contrast, over 70% of  		community-dwelling beneficiaries with cardiovascular conditions have private  		health insurance and less than 15% have Medicaid coverage. The last row in this  		table shows that nearly one-third of the institutional population changed their  		living situation during the year.</p>
<p><i>Health status.</i> The two groups also differ by types of  		cardiovascular disease, concomitant illnesses, functional status, and mortality  		rates. As <a href="medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease.html#table3">Table 3</a> shows, facility-dwelling beneficiaries  		tend to exhibit more advanced forms of heart disease than their counterparts in  		the community, and they often have co-existing illnesses that can complicate  		the selection of cardiovascular agents. Almost 70% of all cardiovascular  		treatment in the institutional setting was for heart failure, cardiomyopathy or  		other complications of heart disease compared to 45% in the community. About  		25% of the institutional population had artherosclerosis (compared to 8% in the  		community). Only hypertensive disease was more common in the community-dwelling  		population (80% vs. 68%). More than one-third of the institutional population  		was treated for three or more types of heart disease during the year (vs. 22%  		in the community). Institutionalized residents with heart disease more often  		suffered from concomitant conditions such as mental disorders (70%),  		cerebrovascular disease (37%), and diabetes (30%). In contrast, less than 25%  		of community-dwelling beneficiaries with heart disease had evidence of any of  		these chronic conditions. Given this difference in disease burden, it is not  		surprising to find that institutional beneficiaries with heart disease were  		twice as likely as their community counterparts to report poor general health  		status and 52% had difficulty performing five or more activities of daily  		living (vs. 4% in the community). Lastly, nearly one-quarter of the  		institutional population with heart disease died during the year compared to 4%  		of the community-dwelling population.</p>
<p><i>Use of cardiovascular medications</i>. Use of heart medications was  		similar in some ways across the two populations, although facility residents  		were less likely to use certain classes of heart drugs (see <a href="medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease.html#table4">Table 4</a>). Among beneficiaries treated for heart disease,  		nearly all (80%) used some type of cardiovascular drug therapy during the year,  		regardless of residential setting. Diuretics were the most commonly prescribed  		category of heart medications for both groups (50% of institutional residents  		vs. 40% of community residents). Use of ACE inhibitors--the second most common  		heart medicine--was also similar (27% of institutional residents vs. 25% of  		community residents). Large differences were noted though in the prescribing of  		the following categories of drugs: institutionalized beneficiaries with heart  		disease were three times <i>less likely </i>to be prescribed  		cholesterol-lowering agents (6% vs. 19%) as those treated in the outpatient  		setting, two times <i>less likely</i> to take beta-blockers (12% vs. 24%), and  		one-third <i>less likely</i> to take calcium channel blockers (22% vs. 30%).  		Institutionalized beneficiaries were <i>more likely</i> than community  		beneficiaries to use digitalis (24% vs. 14%).</p>
<p><i>Use of non-cardiovascular medications</i>. <a href="medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease.html#table5">Table  		5</a> provides information about the other medications that these populations  		used while being treated for heart disease. In 27 of 28 cases, facility  		residents had higher rates of drug use in non-cardiovascular therapeutic  		classes than the community-dwellers. Particular differences in these types of  		drug used between the institutional and community populations include: narcotic  		analgesics (30% vs. 18%), antibiotics (52% vs. 26%), antidepressants (39% vs.  		14%), antipsychotics (22% vs. 2%), anti-ulcer agents (34% vs. 18%) and  		bronchodilators (19% vs. 9%).</p>
<h2><a name="discuss" id="discuss">DISCUSSION</a></h2>
<p>These national estimates of cardiovascular drug use by Medicare  		beneficiaries with heart disease serve as the first comparison in a consistent  		dataset of prescribing patterns across long-term care and outpatient settings.  		The comparison shows that medication use and disease burden varied greatly for  		beneficiaries depending on their residence. These differences are important  		when evaluating population-level patterns of care because prescribers must  		assess both the type of heart disease and the potential for interaction with  		concomitant conditions or therapies when selecting cardiovascular agents.  		Nevertheless, the lower use of some heart medicines in the institutional  		setting was notable given the severity of cardiovascular disease in this  		population. Since facility residents tended to use more medications than  		community residents in 27 of 28 other major drug categories, the lower use of  		some types of heart medicines (especially those used in secondary prevention)  		is anomalous. Future research should assess the possibility of under-treatment  		of cardiovascular disease in institutional settings.</p>
<p>The analysis also demonstrates some of the capabilities and challenges  		of using the new MCBS institutional drug administration file. As noted earlier,  		the MCBS captures medication use in the community as self-reported prescription  		fills while medication use in institutions is monthly record abstracts of drug  		administrations. This difference presented several analytic complexities.  		First, drug use in the community suffers from some under-reporting bias  		(estimated at about 15%) not evident in the institutional drug records. Thus,  		the differences in cardiovascular medication use that we observed between the  		two settings may be even greater than reported here. Second, the distinction  		between administered drugs versus filled prescriptions may have influenced the  		capture of drugs, although we excluded any medications never administered in  		institutions to address this concern. Third, the distinction of  		over-the-counter versus prescribed drugs does not exist in the institutional  		setting, but it does in the community. We excluded over-the-counter medications  		such as aspirin to address this source of potential bias, nevertheless  		prescribing patterns are surely influenced by this systematic difference.  		Despite these challenges, the MCBS institutional drug administration file  		allowed for new insights into the medication use of beneficiaries in long-term  		care facilities.</p>
<table title="TABLE 1. Medicare Beneficiaries with Cardiovascular Disease by Living Situation, 1998"><tr><td colspan="3"><font><b><a name="table1" id="table1">TABLE 1</a>. Medicare Beneficiaries with  			 Cardiovascular Disease by Living Situation, 1998</b></font></td>
</tr><tr><td scope="col"><font><b>Type of Heart Disease</b></font></td>
<td scope="col"><font><b>  Institutionalized  Beneficiaries(N=2.3  			 million)</b></font></td>
<td scope="col"><font><b>  Community-Dwelling  Beneficiaries(N=30.6  			 million)</b></font></td>
</tr><tr><td scope="row"><font>Any Heart  			 Disease*</font></td>
<td><font>75.6%</font></td>
<td><font>57.6%</font></td>
</tr><tr><td scope="row"><font>Chronic  			 Rheumatic Heart Disease</font></td>
<td><font>2.9</font></td>
<td><font>2.2</font></td>
</tr><tr><td scope="row"><font>Hypertensive  			 Disease</font></td>
<td><font>51.1</font></td>
<td><font>46.3</font></td>
</tr><tr><td scope="row"><font>Ischemic  			 Heart Disease</font></td>
<td><font>31.2</font></td>
<td><font>21.5</font></td>
</tr><tr><td scope="row"><font>Pulmonary  			 Heart Disease</font></td>
<td><font>2.4</font></td>
<td><font>1.8</font></td>
</tr><tr><td scope="row"><font>Heart  			 Failure, Cardiomyopathy and Other Complications of Heart  			 Disease  </font></td>
<td><font>52.0</font></td>
<td><font>25.9</font></td>
</tr><tr><td scope="row"><font>Atherosclerosis</font></td>
<td><font>19.3</font></td>
<td><font>4.8</font></td>
</tr><tr><td colspan="3" scope="row"><font><b>SOURCE</b>: Medicare Current Beneficiary Survey, 1998* Only  			 includes heart diseases listed below. Refer to Appendix <a href="medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease.html#tableA1">Table A1</a> for details.</font></td>
</tr></table><table title="TABLE 2. Characteristics of Medicare Beneficiaries with Cardiovascular Disease by Living Situation, 1998"><tr><td colspan="3"><font><b><a name="table2" id="table2">TABLE 2</a>. Characteristics of Medicare  			 Beneficiaries with Cardiovascular Disease by Living Situation,  			 1998</b></font></td>
</tr><tr><td scope="col"><font><b>Beneficiary Characteristics</b></font></td>
<td scope="col"><font><b>  Institutionalized  Beneficiaries(N=1.7  			 million)</b></font></td>
<td scope="col"><font><b>  Community-Dwelling  Beneficiaries(N=17.6  			 million)</b></font></td>
</tr><tr><td colspan="3" scope="row"><font>Age (years)</font></td>
</tr><tr><td scope="row"><font>   Under 65</font></td>
<td><font>5.9%</font></td>
<td><font>9.1%</font></td>
</tr><tr><td scope="row"><font>   65-74</font></td>
<td><font>10.7</font></td>
<td><font>41.6</font></td>
</tr><tr><td scope="row"><font>   75-84</font></td>
<td><font>31.5</font></td>
<td><font>37.3</font></td>
</tr><tr><td scope="row"><font>   85-94</font></td>
<td><font>42.4</font></td>
<td><font>11.4</font></td>
</tr><tr><td scope="row"><font>   95+</font></td>
<td><font>9.4</font></td>
<td><font>0.7</font></td>
</tr><tr><td colspan="3" scope="row"><font>Gender</font></td>
</tr><tr><td scope="row"><font>   Female</font></td>
<td><font>70.6</font></td>
<td><font>57.3</font></td>
</tr><tr><td scope="row"><font>   Male</font></td>
<td><font>29.4</font></td>
<td><font>42.7</font></td>
</tr><tr><td colspan="3" scope="row"><font>Race</font></td>
</tr><tr><td scope="row"><font>   White</font></td>
<td><font>87.1</font></td>
<td><font>85.9</font></td>
</tr><tr><td scope="row"><font>   Non-white</font></td>
<td><font>12.9</font></td>
<td><font>14.1</font></td>
</tr><tr><td colspan="3" scope="row"><font>Income</font></td>
</tr><tr><td scope="row"><font>   &lt;$5,000</font></td>
<td><font>15.1</font></td>
<td><font>6.9</font></td>
</tr><tr><td scope="row"><font>   $5,000-$10,000</font></td>
<td><font>43.6</font></td>
<td><font>32.7</font></td>
</tr><tr><td scope="row"><font>   $10,001-$20,000</font></td>
<td><font>25.6</font></td>
<td><font>37.7</font></td>
</tr><tr><td scope="row"><font>   $20,001-$30,000</font></td>
<td><font>9.6</font></td>
<td><font>13.3</font></td>
</tr><tr><td scope="row"><font>   &gt;$30,000</font></td>
<td><font>6.1</font></td>
<td><font>9.4</font></td>
</tr><tr><td colspan="3" scope="row"><font>Urban/Rural Residence</font></td>
</tr><tr><td scope="row"><font>   Urban</font></td>
<td><font>69.9</font></td>
<td><font>71.4</font></td>
</tr><tr><td scope="row"><font>   Rural</font></td>
<td><font>30.1</font></td>
<td><font>28.6</font></td>
</tr><tr><td colspan="3" scope="row"><font>Census Region</font></td>
</tr><tr><td scope="row"><font>   Midwest</font></td>
<td><font>34.2</font></td>
<td><font>24.4</font></td>
</tr><tr><td scope="row"><font>   South</font></td>
<td><font>32.9</font></td>
<td><font>38.6</font></td>
</tr><tr><td scope="row"><font>   Northeast</font></td>
<td><font>21.5</font></td>
<td><font>23.7</font></td>
</tr><tr><td scope="row"><font>   West</font></td>
<td><font>11.4</font></td>
<td><font>13.4</font></td>
</tr><tr><td colspan="3" scope="row"><font>Source of Medicare Supplemental Coverage</font></td>
</tr><tr><td scope="row"><font>   Private only</font></td>
<td><font>23.4</font></td>
<td><font>70.2</font></td>
</tr><tr><td scope="row"><font>   Medicaid only</font></td>
<td><font>49.1</font></td>
<td><font>12.2</font></td>
</tr><tr><td scope="row"><font>   Private and Medicaid  </font></td>
<td><font>12.2</font></td>
<td><font>1.9</font></td>
</tr><tr><td scope="row"><font>   Other</font></td>
<td><font>9.0</font></td>
<td><font>10.1</font></td>
</tr><tr><td scope="row"><font>No Medicare  			 Supplemental Coverage</font></td>
<td><font>6.4</font></td>
<td><font>5.6</font></td>
</tr><tr><td colspan="3" scope="row"><font>Lived in Community Any Time During the Year</font></td>
</tr><tr><td scope="row"><font>   Yes</font></td>
<td><font>29.5</font></td>
<td><font>100.0</font></td>
</tr><tr><td scope="row"><font>   No</font></td>
<td><font>70.5</font></td>
<td><font>---</font></td>
</tr><tr><td colspan="3" scope="row"><font><b>SOURCE</b>: Medicare Current Beneficiary Survey, 1998</font></td>
</tr></table><table title="TABLE 3. Health and Functional Status of Medicare Beneficiaries with Cardiovascular Conditions by Living Situation, 1998"><tr><td colspan="3"><font><b><a name="table3" id="table3">TABLE 3</a>. Health and Functional Status  			 of Medicare Beneficiaries with Cardiovascular Conditions by Living Situation,  			 1998</b></font></td>
</tr><tr><td scope="col"><font><b>Beneficiary Characteristics</b></font></td>
<td scope="col"><font><b>  Institutionalized  Beneficiaries(N=1.7  			 million)</b></font></td>
<td scope="col"><font><b>  Community-Dwelling  Beneficiaries(N=17.6  			 million)</b></font></td>
</tr><tr><td colspan="3" scope="row"><font>Type of Heart Disease</font></td>
</tr><tr><td scope="row"><font>   Chronic reheumatic heart disease</font></td>
<td><font>3.9%</font></td>
<td><font>3.7%</font></td>
</tr><tr><td scope="row"><font>   Hypertensive disease</font></td>
<td><font>67.6</font></td>
<td><font>80.4</font></td>
</tr><tr><td scope="row"><font>   Ischemic heart disease</font></td>
<td><font>41.3</font></td>
<td><font>37.3</font></td>
</tr><tr><td scope="row"><font>   Pulmonary heart disease</font></td>
<td><font>3.1</font></td>
<td><font>3.1</font></td>
</tr><tr><td scope="row"><font>   Heart failure, cardiomyopathy and other  			 complications of heart disease  </font></td>
<td><font>68.8</font></td>
<td><font>44.9</font></td>
</tr><tr><td scope="row"><font>   Atherosclerosis</font></td>
<td><font>25.5</font></td>
<td><font>8.3</font></td>
</tr><tr><td colspan="3" scope="row"><font>Number of Heart Disease Types*</font></td>
</tr><tr><td scope="row"><font>   1</font></td>
<td><font>35.1</font></td>
<td><font>50.3</font></td>
</tr><tr><td scope="row"><font>   2</font></td>
<td><font>30.0</font></td>
<td><font>27.8</font></td>
</tr><tr><td scope="row"><font>   3</font></td>
<td><font>26.3</font></td>
<td><font>16.7</font></td>
</tr><tr><td scope="row"><font>   4 or more</font></td>
<td><font>8.6</font></td>
<td><font>5.2</font></td>
</tr><tr><td colspan="3" scope="row"><font>Other Chronic Conditions**</font></td>
</tr><tr><td scope="row"><font>   Diabetes</font></td>
<td><font>30.4</font></td>
<td><font>24.8</font></td>
</tr><tr><td scope="row"><font>   Cerebrovascular disease</font></td>
<td><font>37.4</font></td>
<td><font>15.9</font></td>
</tr><tr><td scope="row"><font>   Mental disorder</font></td>
<td><font>70.2</font></td>
<td><font>20.0</font></td>
</tr><tr><td scope="row"><font>   Alzheimer's</font></td>
<td><font>20.1</font></td>
<td><font>1.2</font></td>
</tr><tr><td scope="row"><font>   Osteoporosis</font></td>
<td><font>11.9</font></td>
<td><font>9.1</font></td>
</tr><tr><td scope="row"><font>   Arthritis</font></td>
<td><font>34.9</font></td>
<td><font>31.1</font></td>
</tr><tr><td scope="row"><font>   Asthma/COPD</font></td>
<td><font>12.6</font></td>
<td><font>11.0</font></td>
</tr><tr><td scope="row"><font>   Cancer</font></td>
<td><font>21.2</font></td>
<td><font>29.4</font></td>
</tr><tr><td colspan="3" scope="row"><font>Number of Other Chronic Conditions</font></td>
</tr><tr><td scope="row"><font>   0</font></td>
<td><font>7.6</font></td>
<td><font>22.3</font></td>
</tr><tr><td scope="row"><font>   1-2</font></td>
<td><font>45.6</font></td>
<td><font>59.0</font></td>
</tr><tr><td scope="row"><font>   3-4</font></td>
<td><font>39.5</font></td>
<td><font>16.9</font></td>
</tr><tr><td scope="row"><font>   5 or more</font></td>
<td><font>7.3</font></td>
<td><font>1.8</font></td>
</tr><tr><td colspan="3" scope="row"><font>General Health Status</font></td>
</tr><tr><td scope="row"><font>   Excellent to Very Good</font></td>
<td><font>7.8</font></td>
<td><font>34.5</font></td>
</tr><tr><td scope="row"><font>   Good</font></td>
<td><font>27.8</font></td>
<td><font>33.3</font></td>
</tr><tr><td scope="row"><font>   Fair</font></td>
<td><font>44.1</font></td>
<td><font>21.3</font></td>
</tr><tr><td scope="row"><font>   Poor</font></td>
<td><font>20.4</font></td>
<td><font>10.8</font></td>
</tr><tr><td colspan="3" scope="row"><font>Activities of Daily Living (ADL) Limitations</font></td>
</tr><tr><td scope="row"><font>   0</font></td>
<td><font>9.8</font></td>
<td><font>66.6</font></td>
</tr><tr><td scope="row"><font>   1-2</font></td>
<td><font>23.1</font></td>
<td><font>21.5</font></td>
</tr><tr><td scope="row"><font>   3-4</font></td>
<td><font>15.6</font></td>
<td><font>7.5</font></td>
</tr><tr><td scope="row"><font>   5-6</font></td>
<td><font>51.5</font></td>
<td><font>4.4</font></td>
</tr><tr><td scope="row"><font>Died During  			 the Year</font></td>
<td><font>25.5</font></td>
<td><font>4.4</font></td>
</tr><tr><td colspan="3" scope="row"><font><b>SOURCE</b>: Medicare Current Beneficiary Survey, 1998 * Count  			 includes chronic rheumatic heart disease, hypertensive disease, ischemic heart  			 disease, pulmonary heart disease, other forms of heart disease,  			 atherosclerosis.** Identified from claims data in 1998.</font></td>
</tr></table><table title="TABLE 4. Prevalence of Cardiovascular Medication Use by Medicare Beneficiaries with Cardiovascular Disease by Living Situation, 1998"><tr><td colspan="3"><font><b><a name="table4" id="table4">TABLE 4</a>. Prevalence of Cardiovascular  			 Medication Use by Medicare Beneficiaries with Cardiovascular Disease by Living  			 Situation, 1998*</b></font></td>
</tr><tr><td scope="col"><font><b>Therapeutic Class</b></font></td>
<td scope="col"><font><b>  Institutionalized  Beneficiaries%  			 With Any Use(N=1.7 million)</b></font></td>
<td scope="col"><font><b>  Community-Dwelling  Beneficiaries%  			 With Any Use(N=17.6 million)</b></font></td>
</tr><tr><td scope="row"><font>Any  			 Cardiovascular Medication**  </font></td>
<td><font>78.9%</font></td>
<td><font>79.0%</font></td>
</tr><tr><td scope="row"><font>Diuretics</font></td>
<td><font>49.9</font></td>
<td><font>39.4</font></td>
</tr><tr><td scope="row"><font>ACE  			 Inhibitors</font></td>
<td><font>27.3</font></td>
<td><font>25.4</font></td>
</tr><tr><td scope="row"><font>Digitalis</font></td>
<td><font>24.0</font></td>
<td><font>13.6</font></td>
</tr><tr><td scope="row"><font>Calcium  			 Channel Blockers</font></td>
<td><font>21.6</font></td>
<td><font>30.0</font></td>
</tr><tr><td scope="row"><font>Vasocoronary  			 Agents</font></td>
<td><font>19.1</font></td>
<td><font>14.0</font></td>
</tr><tr><td scope="row"><font>Beta-Blockers</font></td>
<td><font>11.8</font></td>
<td><font>24.4</font></td>
</tr><tr><td scope="row"><font>Antiadrenergic Agents</font></td>
<td><font>10.7</font></td>
<td><font>9.5</font></td>
</tr><tr><td scope="row"><font>Cholesterol-Lowering Agents</font></td>
<td><font>5.5</font></td>
<td><font>19.1</font></td>
</tr><tr><td scope="row"><font>Antiplatelet</font></td>
<td><font>4.3</font></td>
<td><font>2.9</font></td>
</tr><tr><td scope="row"><font>Angiotensin-Receptor Blockers</font></td>
<td><font>3.0*</font></td>
<td><font>4.1</font></td>
</tr><tr><td scope="row"><font>Antiarrhythmic</font></td>
<td><font>2.2*</font></td>
<td><font>2.9</font></td>
</tr><tr><td scope="row"><font>Vasodilator</font></td>
<td><font>0.8*</font></td>
<td><font>0.9</font></td>
</tr><tr><td colspan="3" scope="row"><font><b>SOURCE</b>: Medicare Current Beneficiary Survey, 1998* Cell  			 size less than 20** Only includes cardiovascular medications listed below.  			 Does not include over-the-counter medications such as aspirin</font></td>
</tr></table><table title="TABLE 5. Prevalence of Non-Cardiovascular Medication Use by Medicare Beneficiaries with Cardiovascular Diseases by Living Situation, 1998"><tr><td colspan="3"><font><b><a name="table5" id="table5">TABLE 5</a>. Prevalence of  			 Non-Cardiovascular Medication Use by Medicare Beneficiaries with Cardiovascular  			 Diseases by Living Situation, 1998</b></font></td>
</tr><tr><td scope="col"><font><b>Therapeutic Class</b></font></td>
<td scope="col"><font><b>  Institutionalized  Beneficiaries%  			 With Any Use(N=1.7 million)</b></font></td>
<td scope="col"><font><b>  Community-Dwelling  Beneficiaries%  			 With Any Use(N=17.6 million)</b></font></td>
</tr><tr><td scope="row"><font>Analgesics,  			 Narcotics</font></td>
<td><font>29.7%</font></td>
<td><font>17.8%</font></td>
</tr><tr><td scope="row"><font>NSAIDs,  			 Cyclooxygenase Inhibitor - type  </font></td>
<td><font>18.0</font></td>
<td><font>16.8*</font></td>
</tr><tr><td scope="row"><font>Antihistamines</font></td>
<td><font>16.8</font></td>
<td><font>8.9</font></td>
</tr><tr><td scope="row"><font>Anti-Cancer  			 Agents</font></td>
<td><font>3.5</font></td>
<td><font>2.2</font></td>
</tr><tr><td scope="row"><font>Antibiotics</font></td>
<td><font>51.7</font></td>
<td><font>26.2</font></td>
</tr><tr><td scope="row"><font>Antibacterials</font></td>
<td><font>14.6</font></td>
<td><font>5.4</font></td>
</tr><tr><td scope="row"><font>Antifungal  			 Agents</font></td>
<td><font>7.1</font></td>
<td><font>2.9</font></td>
</tr><tr><td scope="row"><font>Antiparasitic  			 Agents</font></td>
<td><font>3.7</font></td>
<td><font>2.0</font></td>
</tr><tr><td scope="row"><font>Antiviral  			 Agents</font></td>
<td><font>3.1</font></td>
<td><font>1.0</font></td>
</tr><tr><td scope="row"><font>Anti-Alzheimer Agents</font></td>
<td><font>5.8</font></td>
<td><font>1.0</font></td>
</tr><tr><td scope="row"><font>Alpha-Adrenergic Blockers</font></td>
<td><font>4.9</font></td>
<td><font>6.9</font></td>
</tr><tr><td scope="row"><font>Anticholinergic Agents</font></td>
<td><font>3.2</font></td>
<td><font>2.2</font></td>
</tr><tr><td scope="row"><font>Anticoagulants/Thrombolytics</font></td>
<td><font>17.6</font></td>
<td><font>13.2</font></td>
</tr><tr><td scope="row"><font>Antidepressants</font></td>
<td><font>38.8</font></td>
<td><font>14.6</font></td>
</tr><tr><td scope="row"><font>Anxiolytics,  			 Sedatives and Hypnotics</font></td>
<td><font>27.6</font></td>
<td><font>14.6</font></td>
</tr><tr><td scope="row"><font>Antipsychotics</font></td>
<td><font>22.1</font></td>
<td><font>2.1</font></td>
</tr><tr><td scope="row"><font>Anticonvulsants</font></td>
<td><font>13.7</font></td>
<td><font>4.4</font></td>
</tr><tr><td scope="row"><font>Antiparkinsonism Agents</font></td>
<td><font>11.4</font></td>
<td><font>1.8</font></td>
</tr><tr><td scope="row"><font>Miscellaneous, CNS Agents</font></td>
<td><font>11.0</font></td>
<td><font>8.4</font></td>
</tr><tr><td scope="row"><font>Anti-Ulcer  			 Agents</font></td>
<td><font>33.8</font></td>
<td><font>18.1</font></td>
</tr><tr><td scope="row"><font>Intestinal  			 Motility Stimulants</font></td>
<td><font>9.6</font></td>
<td><font>3.4</font></td>
</tr><tr><td scope="row"><font>Adrenocortical Hormones</font></td>
<td><font>9.4</font></td>
<td><font>12.2</font></td>
</tr><tr><td scope="row"><font>Insulin and  			 Anti-Diabetic Agents</font></td>
<td><font>17.8</font></td>
<td><font>11.4</font></td>
</tr><tr><td scope="row"><font>Thyroid and  			 Antithyroid Agents</font></td>
<td><font>14.2</font></td>
<td><font>10.3</font></td>
</tr><tr><td scope="row"><font>Parathyroid/Bone Resorption Drugs</font></td>
<td><font>6.3</font></td>
<td><font>3.9</font></td>
</tr><tr><td scope="row"><font>Female  			 Hormonal Agents</font></td>
<td><font>4.8</font></td>
<td><font>10.2</font></td>
</tr><tr><td scope="row"><font>Anti-incontinence/Antispasmodic Agents  </font></td>
<td><font>4.3</font></td>
<td><font>1.2</font></td>
</tr><tr><td scope="row"><font>Bronchodilators</font></td>
<td><font>19.0</font></td>
<td><font>9.2</font></td>
</tr><tr><td colspan="3" scope="row"><font><b>SOURCE</b>: Medicare Current Beneficiary Survey, 1998.* Does  			 not include over-the-counter medications and hence is an underestimate.**  			 Therapeutic classes with cell sizes less than 20 are not reported.</font></td>
</tr></table><h2><a name="append" id="append">APPENDIX</a></h2>
<table title="TABLE A1. Unweighted Sample Sizes Based on Claims Data"><tr><td colspan="4"><font><b><a name="tableA1" id="tableA1">TABLE A1</a>. Unweighted Sample Sizes  			 Based on Claims Data</b></font></td>
</tr><tr><td rowspan="2" scope="col"><font><b>Type of Cardiovascular  			 Disease</b></font></td>
<td scope="col"><font><b>Specific  Conditions  </b></font></td>
<td scope="col"><font><b>  Institutionalized  Beneficiaries</b></font></td>
<td scope="col"><font><b>Community-Dwelling  Beneficiaries  </b></font></td>
</tr><tr><td scope="col"><font><b>ICD-9-CMCodes</b></font></td>
<td scope="col"><font><b>UnweightedN (%)</b></font></td>
<td scope="col"><font><b>UnweightedN (%)</b></font></td>
</tr><tr><td scope="row"><font>Total</font></td>
<td><font> </font></td>
<td><font>821</font></td>
<td><font>5692</font></td>
</tr><tr><td scope="row"><font>Hypertensive  			 Disease</font></td>
<td><font>401.xx-405.xx</font></td>
<td><font>547 (66.6)%</font></td>
<td><font>4561  			 (80.1%)</font></td>
</tr><tr><td scope="row"><font>Heart  			 Failure, Cardiomyopathy and Other Complications of Heart  			 Disease*  </font></td>
<td><font>424.0-424.3,  			 425.xx-428.xx, 429.0-429.2</font></td>
<td><font>567 (69.1%)</font></td>
<td><font>2645  			 (46.5%)</font></td>
</tr><tr><td scope="row"><font>Ischemic  			 Heart Disease</font></td>
<td><font>410.xx-414.xx</font></td>
<td><font>329 (40.1%)</font></td>
<td><font>2135  			 (37.5%)</font></td>
</tr><tr><td scope="row"><font>Atherosclerosis</font></td>
<td><font>440.xx</font></td>
<td><font>206 (25.1%)</font></td>
<td><font>496 (8.7%)</font></td>
</tr><tr><td scope="row"><font>Chronic  			 Rheumatic Heart Disease</font></td>
<td><font>394.0, 394.2, 395.0,  			 395.2, 396.0-396.8, 397.0, 398.90, 398.91</font></td>
<td><font>31 (3.8%)</font></td>
<td><font>232 (4.1%)</font></td>
</tr><tr><td scope="row"><font>Pulmonary  			 Heart Disease</font></td>
<td><font>415.xx,  			 416.xx</font></td>
<td><font>23 (2.8%)</font></td>
<td><font>186 (3.3%)</font></td>
</tr><tr><td colspan="4" scope="row"><font><b>SOURCE</b>: Medicare Current Beneficiary Survey, 1998*  			 Includes valve disorders, cardiomyopathy, conduction disorders, cardiac  			 dysrhythmias, heart failure, and ill-defined descriptions and complications of  			 heart disease.</font></td>
</tr></table><table title="TABLE A2&lt;/A&gt;. Distribution of Sample by  &#9;&#9;&#9; the Number of Cardiovascular-Related Claims in 1998"><tr><td colspan="3"><font><b><a name="tableA2" id="tableA2">TABLE A2</a>. Distribution of Sample by  			 the Number of Cardiovascular-Related Claims in 1998</b></font></td>
</tr><tr><td scope="col"><font><b>  Beneficiary  			 Characteristics  </b></font></td>
<td scope="col"><font><b>  Institutionalized  BeneficiariesUnweighted  			 N (%)</b></font></td>
<td scope="col"><font><b>  Community-Dwelling  BeneficiariesUnweighted  			 N (%)</b></font></td>
</tr><tr><td scope="row"><font>Total</font></td>
<td><font>821</font></td>
<td><font>5692</font></td>
</tr><tr><td colspan="3" scope="row"><font>Number of Cardiovascular-Related Claims in 1998</font></td>
</tr><tr><td scope="row"><font>   1</font></td>
<td><font>56 (6.8%)</font></td>
<td><font>493 (8.7%)</font></td>
</tr><tr><td scope="row"><font>   2</font></td>
<td><font>44 (5.4%)</font></td>
<td><font>378 (6.6%)</font></td>
</tr><tr><td scope="row"><font>   3 or more  </font></td>
<td><font>721 (87.8%)</font></td>
<td><font>4821  			 (84.7%)</font></td>
</tr><tr><td colspan="3" scope="row"><font><b>SOURCE</b>: Medicare Current Beneficiary Survey, 1998.</font></td>
</tr></table><hr /><h3><b><i>PRESCRIPTION DRUGS AND PEOPLE WITH DISABILITIES: A PRIMER FOR  		DATA AND RESEARCH</i> REPORTS AVAILABLE</b></h3>
<dl><dt> <b>Medication Use by Medicare Beneficiaries Living in Nursing Homes  		  and Assisted Living Facilities</b></dt>
<dd> HTML   <a href="http://aspe.hhs.gov/daltcp/reports/2002/meduse.htm">http://aspe.hhs.gov/daltcp/reports/2002/meduse.htm</a></dd>
<dd> PDF   <a href="http://aspe.hhs.gov/daltcp/reports/2002/meduse.pdf">http://aspe.hhs.gov/daltcp/reports/2002/meduse.pdf</a></dd>
</dl><dl><dt><b>Medication Use in Long-Term Care Facilities and Community Settings  		  for Medicare Beneficiaries with Cardiovascular Disease</b></dt>
<dd>Full HTML Version   <a href="http://aspe.hhs.gov/daltcp/reports/2002/cdmeduse.htm">http://aspe.hhs.gov/daltcp/reports/2002/cdmeduse.htm</a></dd>
<dd>Full PDF Version   <a href="../system/files/pdf/73251/cdmeduse.pdf">http://aspe.hhs.gov/daltcp/reports/2002/cdmeduse.pdf</a></dd>
</dl><dl><dt> <b>The Graying of Medicare's Disabled Population: Implication for a  		  Medicare Drug Benefit</b></dt>
<dd> Executive Summary   <a href="http://aspe.hhs.gov/daltcp/reports/2002/grayinges.htm">http://aspe.hhs.gov/daltcp/reports/2002/grayinges.htm</a></dd>
<dd> HTML   <a href="http://aspe.hhs.gov/daltcp/reports/2002/graying.htm">http://aspe.hhs.gov/daltcp/reports/2002/graying.htm</a></dd>
<dd> PDF   <a href="http://aspe.hhs.gov/daltcp/reports/2002/graying.pdf">http://aspe.hhs.gov/daltcp/reports/2002/graying.pdf</a></dd>
</dl><hr /><p>To obtain a printed copy of this report, send the full report title and  		your mailing information to:</p>
<blockquote><p>U.S. Department of Health and Human ServicesOffice of Disability,  		  Aging and Long-Term Care PolicyRoom 424E, H.H. Humphrey Building200  		  Independence Avenue, S.W.Washington, D.C.  		  20201FAX:  202-401-7733Email:  <a href="mailto: webmaster.DALTCP@hhs.gov">webmaster.DALTCP@hhs.gov</a></p>
</blockquote>
<hr /><p class="lastupdated"><b>RETURN TO:</b> </p>
<p class="lastupdated">Office of Disability, Aging and  		Long-Term Care Policy (DALTCP) Home [<a href="../_/office_specific/daltcp.cfm.html">http://aspe.hhs.gov/_/office_specific/daltcp.cfm</a>]Assistant  		Secretary for Planning and Evaluation (ASPE) Home [<a href="../index.html">http://aspe.hhs.gov</a>]U.S. Department of  		Health and Human Services Home [<a href="http://www.hhs.gov">http://www.hhs.gov</a>]</p>

  <div class="download_report">
    
                        <div class="pdf-prev">
                <img src="https://aspe.hhs.gov/system/files/pdfpreview/26c870efdadd79e4d937764ab6fd6a2d.png" alt="Preview" title="Preview" />            </div>
                <a class="btn btn-sm btn-default download-file"
           href="../system/files/pdf/73251/cdmeduse.pdf">Download</a>

        <p class="download_title">&quot;cdmeduse.pdf&quot;
            (pdf,
            2.55Mb)</p>
        <p>Note: Documents in PDF format require the <a href="http://www.adobe.com/products/acrobat/readstep2.html">Adobe
                Acrobat Reader&reg;</a>. If you experience problems with PDF documents, please <a
                href="http://www.adobe.com/products/acrobat/readstep2.html">download the latest version of the
                Reader&reg;</a>
        </p>
    </div>
<div class="group-tags"><div class="field-label">Tags:&nbsp;</div><a href="../terms/long-term-care-facilities.html">Long-Term Care Facilities</a><a href="../terms/publications-2.html">Publications</a><a href="../terms/disability-aging-and-long-term-care-research.html">Disability, Aging and Long-Term Care Research</a><a href="../taxonomy/term/16266.1.html">Long-Term Care</a></div>  </div>

      <footer>
          </footer>
  
    <div id="block-webform-client-block-158521" class="widget block block-webform" >
  
      
  <div id="webform-ajax-wrapper-158521"><form class="webform-client-form webform-client-form-158521" action="medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease.html" method="post" id="webform-client-form-158521" accept-charset="UTF-8"><div><div class="webform-progressbar">
  

  
  </div>
<div  class="form-item webform-component webform-component-radios webform-component--was-this-page-helpful">
  <label for="edit-submitted-was-this-page-helpful">Was this page helpful? <span class="form-required" title="This field is required.">*</span></label>
 <div id="edit-submitted-was-this-page-helpful" class="form-radios"><div class="form-type-radio form-item-submitted-was-this-page-helpful form-item radio">
 <input required="required" type="radio" id="edit-submitted-was-this-page-helpful-1" name="submitted[was_this_page_helpful]" value="1" class="form-radio" />  <label for="edit-submitted-was-this-page-helpful-1">Yes </label>

</div>
<div class="form-type-radio form-item-submitted-was-this-page-helpful form-item radio">
 <input required="required" type="radio" id="edit-submitted-was-this-page-helpful-2" name="submitted[was_this_page_helpful]" value="0" class="form-radio" />  <label for="edit-submitted-was-this-page-helpful-2">No </label>

</div>
</div>
</div>
<input type="hidden" name="details[sid]" />
<input type="hidden" name="details[page_num]" value="1" />
<input type="hidden" name="details[page_count]" value="4" />
<input type="hidden" name="details[finished]" value="0" />
<input type="hidden" name="form_build_id" value="form-kHlosSBRjee5ekcnb7HUeeMb70UpwPjrdMqqw_YC_KQ" />
<input type="hidden" name="form_id" value="webform_client_form_158521" />
<input type="hidden" name="webform_ajax_wrapper_id" value="webform-ajax-wrapper-158521" />
<div class="form-actions"><input class="webform-next button-primary btn btn-default form-submit" type="submit" id="edit-webform-ajax-next-158521" name="op" value="Next &gt;" /></div>
<div class="is-useful-disclaimer"> <a href="https://aspe.hhs.gov/%23" class="" title="Survey Disclaimer" data-toggle="modal" data-target="#disclamerModal">Form Approved OMB# 0990-0379 Exp. Date 8/31/2017</a></div>
<div class="modal fade" id="disclamerModal" tabindex="-1" role="dialog" aria-labelledby="disclamerModalLabel">
  <div class="modal-dialog" role="document">
    <div class="modal-content">
      <div class="modal-header">
        <button type="button" class="close" data-dismiss="modal" aria-label="Close"><span aria-hidden="true">&times;</span></button>
        <h2 class="modal-title" id="disclamerModalLabel">Survey Disclaimer</h2>
      </div>
      <div class="modal-body">
         According to the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number. The valid OMB control number for this information collection is 0990-0379. The time required to complete this information collection is estimated to average 5 minutes per response, including the time to review instructions, search existing data resources, gather the data needed, and complete and review the information collection. If you have comments concerning the accuracy of the time estimate(s) or suggestions for improving this form, please write to: U.S. Department of Health & Human Services, OS/OCIO/PRA, 200 Independence Ave., S.W., Suite 336-E, Washington D.C. 20201, Attention: PRA Reports Clearance Officer.      </div>
    </div>
  </div>
</div></div></form></div>
  </div> <!-- /.block -->
<meta  itemscope="" itemid="https://aspe.hhs.gov/pdf-report/medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease" itemref="md1" /><meta  itemscope="" itemid="https://aspe.hhs.gov/basic-report/medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease" itemref="md2 md3 md5 md7 md9 md11" /><meta  itemscope="" itemid="https://aspe.hhs.gov/terms/long-term-care-facilities" id="md5" itemref="md4" /><meta  itemscope="" itemid="https://aspe.hhs.gov/terms/publications-2" id="md7" itemref="md6" /><meta  itemscope="" itemid="https://aspe.hhs.gov/terms/disability-aging-and-long-term-care-research" id="md9" itemref="md8" /><meta  itemscope="" itemid="https://aspe.hhs.gov/terms/long-term-care" id="md11" itemref="md10" />              
                          </div>
                              
        
                  
        
                  
        
                  
        
                  
        
      </div>

          </div>
    
    
      </div>
    


      <footer  class="nd-region">
  
       

          <div class = "container">
    
      <div  class="row" id="Footer">     

        
                  
        
                  
        
                  
        
                  
        
                                    <div  id="footer_sitemap-footer_sitemap" class="col-sm-6 col-md-6 col-lg-4 ">
                          
                              <div id="block-footer-sitemap-footer-sitemap" class="widget block block-footer-sitemap" >
  
      
  <div id="footer-sitemap" class="clearfix">
  <div class="fs-block-content"><div class="menu-footer-utility"><ul class="footer_links_menu-footer-utility total-items-2 parent-items-0 single-items-0"><li class="menu-5021 depth-1 total-children-8 parent-children-0 single-children-8  first"><a href="../images/exit_disclaimer.jpg.html" title="look at ASPE Home" class="fs-root-link">ASPE Home</a><ul class="footer_links_menu-footer-utility total-items-8 parent-items-0 single-items-0"><li class="menu-5026 depth-1 fs-no-children  first"><a href="http://www.hhs.gov/" title="look at HHS Home">HHS Home</a></li>
<li class="menu-66281 depth-1 fs-no-children"><a href="http://www.usa.gov/" title="look at USA.gov">USA.gov</a></li>
<li class="menu-66316 depth-1 fs-no-children"><a href="https://oig.hhs.gov/" title="look at Office of the Inspector General">Office of the Inspector General</a></li>
<li class="menu-66321 depth-1 fs-no-children"><a href="http://www.whitehouse.gov" title="look at The White House">The White House</a></li>
<li class="menu-5046 depth-1 fs-no-children"><a href="http://www.hhs.gov/Accessibility.html" title="look at Accessibility">Accessibility</a></li>
<li class="menu-66326 depth-1 fs-no-children"><a href="http://www.hhs.gov/about/budget/index.html" title="look at Budget/Performance">Budget/Performance</a></li>
<li class="menu-2551 depth-1 fs-no-children"><a href="http://www.hhs.gov/Privacy.html" title="look at Privacy Policy">Privacy Policy</a></li>
<li class="menu-197776 depth-1 fs-no-children  last"><a href="https://www.hhs.gov/civil-rights/for-individuals/nondiscrimination/index.html" title="Nondiscrimination Notice">Nondiscrimination Notice</a></li>
</ul></li>
<li class="menu-5051 depth-1 total-children-4 parent-children-0 single-children-4  last"><a href="http://www.hhs.gov/foia/" title="look at FOIA" class="fs-root-link">FOIA</a><ul class="footer_links_menu-footer-utility total-items-4 parent-items-0 single-items-0"><li class="menu-5056 depth-1 fs-no-children  first"><a href="http://www.hhs.gov/open/recordsandreports/plainwritingact/index.html" title="look at Plain Writing Act">Plain Writing Act</a></li>
<li class="menu-5061 depth-1 fs-no-children"><a href="http://www.hhs.gov/asa/eeo/no_fear_bullet_3.html" title="look at No Fear Act">No Fear Act</a></li>
<li class="menu-5066 depth-1 fs-no-children"><a href="http://www.hhs.gov/Disclaimer.html" title="look at Disclaimers">Disclaimers</a></li>
<li class="menu-2546 depth-1 fs-no-children  last"><a href="http://www.hhs.gov/plugins.html" title="look at Viewers &amp; Players">Viewers &amp; Players</a></li>
</ul></li>
</ul></div>
</div>
</div>

  </div> <!-- /.block -->
              
                          </div>
                              
        
                                    <div  class="col-sm-6 col-md-6 col-lg-5 " id="stability_cms-contact_us">
                          
                              <div id="block-stability-cms-contact-us" class="widget block block-stability-cms" >
  
      
  <div class="contacts-widget widget widget__footer">
	<div class="widget-content">
		<ul class="contacts-info-list">
      			<li>
<!--				<i class="fa fa-map-marker">Address</i>-->
                <div class="info-icons">
                    <img  alt="map" class= 'map-icons' src="../sites/all/themes/stability/stability_aspe/images/map.png"/>
                </div>
                <div class="info-item">
					Assistant Secretary for Planning and Evaluation, Room 415F<br />
U.S. Department of Health and Human Services<br />
200 Independence Avenue, SW<br />
Washington, D.C. 20201				</div>
			</li>
            			<li>
<!--				<i class="fa fa-phone">phone</i>-->
                <div class="info-icons">
                    <img alt="phone" src="../sites/all/themes/stability/stability_aspe/images/phone.png"/>
                </div>
				<div class="info-item">
					+1 202.690.7858				</div>
			</li>
            			<li>
<!--				<i class="fa fa-envelope">email</i>-->
                <div class="info-icons">
                    <img alt="mail" src="../sites/all/themes/stability/stability_aspe/images/mail-white.png"/>
                </div>
				<span class="info-item">
					<a href="mailto:osaspeinfo@hhs.gov">osaspeinfo@hhs.gov</a>
				</span>
			</li>
      			                					</ul>
	</div>
</div>
  </div> <!-- /.block -->
              
                          </div>
                              
        
                                    <div  class="col-sm-6 col-md-6 col-lg-3 " id="footer">
                          
                              <div id="block-block-36" class="widget block block-block" >
  
        <div class="title-accent">
			<h3 class = "widget-title" ><span>Sign-up</span> for Email Updates</h3>
		</div>
    
  <div class="email_updates">
<button class="btn btn-default" name="subscribe-button" type="submit" value="subscribe">subscribe</button>
</div>
  </div> <!-- /.block -->
              
                          </div>
                              
        
                                    <div  class="col-sm-6 col-md-6 col-lg-12 " id="menu-menu-footer-language-menu">
                          
                              <div id="block-menu-menu-footer-language-menu" class="widget block block-menu" >
  
        <div class="title-accent">
			<h3 class = "widget-title" ><span>Language</span> Assistance Available</h3>
		</div>
    
  <ul class="menu"><li class="first expanded"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#spanish" title="Español">Español</a><ul><li class="first leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#chinese" title="繁體中文">繁體中文</a></li>
<li class="leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#vietnamese" title="Tiếng Việt">Tiếng Việt</a></li>
<li class="last leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#korean" title="한국어">한국어</a></li>
</ul></li>
<li class="expanded"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#tagalog" title="Tagalog">Tagalog</a><ul><li class="first leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#russian" title="Русский">Русский</a></li>
<li class="leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#arabic" title="العربية">العربية</a></li>
<li class="last leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#creole" title="Kreyòl Ayisyen">Kreyòl Ayisyen</a></li>
</ul></li>
<li class="expanded"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#french" title="Français">Français</a><ul><li class="first leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#polish" title="Polski">Polski</a></li>
<li class="leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#portuguese" title="Português">Português</a></li>
<li class="last leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#italian" title="Italiano">Italiano</a></li>
</ul></li>
<li class="last expanded"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#german" title="Deutsch">Deutsch</a><ul><li class="first leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#japanese" title="日本語">日本語</a></li>
<li class="leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#farsi" title="فارسی">فارسی</a></li>
<li class="last leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#english" title="English">English</a></li>
</ul></li>
</ul>
  </div> <!-- /.block -->
              
                          </div>
                              
        
      </div>

          </div>
    
    
      </footer>
    

    <!--/PAGEWATCH-->
    <div class="footer-copyright">
      <div class="container">
        <div class="row">
          <div class="col-sm-6 col-md-4">
                        </div>
          <div class="col-sm-6 col-md-8">
            <div class="social-links-wrapper">
              <span class="social-links-txt">Connect with us</span>
              <ul class="social-links social-links__dark">
                                                  <li><a href="http://twitter.com/hhs_aspe"><img alt="twitter" src="../sites/all/themes/stability/stability_aspe/images/tw-grey.png"/></a></li>
                                <!--                --><!--                  <li><a href="http://--><!--"><img alt="linkedin" src="--><!--/images/linkedin-grey.png"/></a></li>-->
<!--                -->
                                                              </ul>
            </div>
          </div>
        </div>
      </div>
    </div>

  </div>
</div>  <script type="text/javascript" src="../sites/default/files/advagg_js/js__VWRymaMz6HfrhnrcJNGcDiSvLVrvhaXvBa7nrBYy8gc__jntPwP3D6myJZH1jW19fXrk5cYMHGRL8NQION22VSEA__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.js"></script>
<script type="text/javascript" src="https://s7.addthis.com/js/300/addthis_widget.js#pubid=ra-5486d15a696bff0c"></script>
<script type="text/javascript" src="../sites/default/files/advagg_js/js__g6mKbcakHxQkz4ZHYaxdO_xqONINvRMgsHh1zAK-fr0__ATHtEmHaeZ0jidpGU22EkhmPDBSgjD8z0bVDQMI-BIY__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.js"></script>
<script type="text/javascript" src="../sites/default/files/advagg_js/js__KUp4PrfOt9BSXUVl8Ctb3dhCMBe4MNVMeb4Gyorx8yY__7g4BeXscCIZAfuu1vxsCj2RIemg-eEK0QpChP9LDmFQ__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.js"></script>
<script type="text/javascript" src="../sites/default/files/advagg_js/js__PNjAgubM_3xXRLp4uLsYnv8wQAdT89-RYkSPxT6T45c__rFQwFK4pA5ZaWZSF7FPTfKbbpus0h-5IS8ayrNZGrb4__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.js"></script>
<script type="text/javascript" src="../sites/default/files/advagg_js/js__vQiLul2UcfC4nBAR09mhYVBYzRmiNDm2dj3GgSubV38__w84oZe-ZODKe7XnnlbrjV4IWHISOy4PioFEMVgx9hZo__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.js"></script>
<script type="text/javascript" src="../sites/default/files/advagg_js/js__QJw3g0kOdwsv4twSZLP931zBzsHy50VEHpEN_znIitQ__A6QOuWXElDipBM2iChbWhjAAt3KlUwZ-jODoxdpbwiw__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
jQuery.extend(Drupal.settings,{"basePath":"\/","pathPrefix":"","ajaxPageState":{"theme":"stability_aspe","theme_token":"_JtFyoqiEIiXzxA5fNpBGtqwSYlTBlJ2J36a4UgKCP0","jquery_version":"1.10","css":{"modules\/system\/system.base.css":1,"modules\/system\/system.messages.css":1,"sites\/all\/modules\/custom\/aspe_nodes\/theme\/css\/footable.css":1,"sites\/all\/modules\/custom\/aspe_nodes\/theme\/css\/aspe_nodes.admin.css":1,"sites\/all\/modules\/custom\/aspe_views\/theme\/css\/aspe_views.admin.css":1,"sites\/all\/modules\/forked\/book\/book.css":1,"profiles\/openpublic\/modules\/contrib\/date\/date_api\/date.css":1,"profiles\/openpublic\/modules\/contrib\/date\/date_popup\/themes\/datepicker.1.7.css":1,"modules\/field\/theme\/field.css":1,"sites\/all\/modules\/contrib\/footer_sitemap\/footer_sitemap.css":1,"modules\/node\/node.css":1,"modules\/user\/user.css":1,"sites\/all\/modules\/contrib\/extlink\/extlink.css":1,"profiles\/openpublic\/modules\/contrib\/views\/css\/views.css":1,"sites\/all\/modules\/contrib\/media\/modules\/media_wysiwyg\/css\/media_wysiwyg.base.css":1,"sites\/all\/libraries\/datatables\/dataTables.responsive.css":1,"profiles\/openpublic\/modules\/contrib\/ctools\/css\/ctools.css":1,"profiles\/openpublic\/modules\/contrib\/panels\/css\/panels.css":1,"profiles\/openpublic\/modules\/contrib\/webform\/css\/webform.css":1,"sites\/default\/files\/css\/follow.css":1,"sites\/all\/themes\/stability\/css\/bootstrap.min.css":1,"sites\/all\/themes\/stability\/css\/fonts\/font-awesome\/css\/font-awesome.min.css":1,"sites\/all\/themes\/stability\/vendor\/owl-carousel\/owl.carousel.css":1,"sites\/all\/themes\/stability\/vendor\/owl-carousel\/owl.theme.css":1,"sites\/all\/themes\/stability\/vendor\/magnific-popup\/magnific-popup.css":1,"sites\/all\/themes\/stability\/vendor\/mediaelement\/mediaelementplayer.css":1,"sites\/all\/themes\/stability\/css\/theme.css":1,"sites\/all\/themes\/stability\/css\/theme-elements.css":1,"sites\/all\/themes\/stability\/css\/animate.min.css":1,"sites\/all\/themes\/stability\/css\/skins\/red.css":1,"sites\/all\/themes\/stability\/stability_aspe\/css\/slideshow.css":1,"sites\/all\/themes\/stability\/stability_aspe\/css\/font-main.css":1,"sites\/all\/themes\/stability\/stability_aspe\/css\/styleless.less":1,"sites\/all\/themes\/stability\/css\/skins\/blue.css":1},"js":{"sites\/all\/modules\/contrib\/jquery_update\/replace\/jquery\/1.10\/jquery.js":1,"misc\/jquery.once.js":1,"misc\/drupal.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/external\/jquery.cookie.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/misc\/jquery.form.js":1,"misc\/ajax.js":1,"sites\/all\/modules\/contrib\/jquery_update\/js\/jquery_update.js":1,"sites\/all\/modules\/custom\/aspe\/theme\/js\/aspe.login-confirm.js":1,"sites\/all\/modules\/custom\/aspe_report\/modules\/aspe_databooks\/js\/aspe_databooks.js":1,"sites\/all\/modules\/custom\/aspe_nodes\/theme\/js\/aspe_nodes.highcharts.js":1,"sites\/all\/modules\/custom\/aspe_nodes\/theme\/js\/aspe_nodes.js":1,"sites\/all\/modules\/contrib\/extlink\/extlink.js":1,"sites\/all\/libraries\/datatables\/dataTables.min.js":1,"sites\/all\/libraries\/datatables\/dataTables.responsive.min.js":1,"sites\/all\/libraries\/highcharts\/highcharts.js":1,"sites\/all\/libraries\/highcharts\/highcharts.exporting.js":1,"sites\/all\/libraries\/highcharts\/highcharts.map.js":1,"sites\/all\/libraries\/highcharts\/highcharts.us-all.js":1,"sites\/all\/modules\/custom\/aspe_nodes\/theme\/js\/aspe_nodes.footable.js":1,"http:\/\/s7.addthis.com\/js\/300\/addthis_widget.js#pubid=ra-5486d15a696bff0c":1,"misc\/progress.js":1,"profiles\/openpublic\/modules\/contrib\/webform\/js\/webform.js":1,"profiles\/openpublic\/modules\/contrib\/field_group\/field_group.js":1,"sites\/all\/themes\/stability\/vendor\/jquery-migrate-1.2.1.min.js":1,"sites\/all\/themes\/stability\/vendor\/bootstrap.js":1,"sites\/all\/themes\/stability\/vendor\/jquery.flexnav.min.js":1,"sites\/all\/themes\/stability\/vendor\/jquery.hoverIntent.minified.js":1,"sites\/all\/themes\/stability\/vendor\/jquery.flickrfeed.js":1,"sites\/all\/themes\/stability\/vendor\/isotope\/jquery.isotope.min.js":1,"sites\/all\/themes\/stability\/vendor\/isotope\/jquery.isotope.sloppy-masonry.min.js":1,"sites\/all\/themes\/stability\/vendor\/isotope\/jquery.imagesloaded.min.js":1,"sites\/all\/themes\/stability\/vendor\/magnific-popup\/jquery.magnific-popup.js":1,"sites\/all\/themes\/stability\/vendor\/owl-carousel\/owl.carousel.min.js":1,"sites\/all\/themes\/stability\/vendor\/jquery.fitvids.js":1,"sites\/all\/themes\/stability\/vendor\/jquery.appear.js":1,"sites\/all\/themes\/stability\/vendor\/jquery.stellar.min.js":1,"sites\/all\/themes\/stability\/vendor\/snap.svg-min.js":1,"sites\/all\/themes\/stability\/js\/custom.js":1,"sites\/all\/themes\/stability\/stability_aspe\/js\/aspe.js":1,"sites\/all\/themes\/stability\/stability_aspe\/js\/html5shiv.min.js":1,"sites\/all\/themes\/stability\/stability_aspe\/js\/main-menu.js":1,"sites\/all\/themes\/stability\/stability_aspe\/js\/keyboard-control.js":1,"sites\/all\/themes\/stability\/stability_aspe\/js\/tabBehavior.js":1,"sites\/all\/themes\/stability\/stability_aspe\/js\/tileStringTrimmer.js":1}},"webform":{"conditionals":{"webform-client-form-158521":{"ruleGroups":[],"sourceMap":[],"values":[]}}},"ajax":{"edit-webform-ajax-next-158521":{"callback":"webform_ajax_callback","wrapper":"webform-ajax-wrapper-158521","progress":{"message":"","type":"throbber"},"event":"click","url":"\/system\/ajax","submit":{"_triggering_element_name":"op","_triggering_element_value":"Next \u003E"}}},"urlIsAjaxTrusted":{"\/system\/ajax":true,"\/basic-report\/medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease":true},"extlink":{"extTarget":"_blank","extClass":0,"extLabel":"(link is external)","extImgClass":0,"extSubdomains":0,"extExclude":"([a-z0-9]\\.gov)","extInclude":"","extCssExclude":"","extCssExplicit":"","extAlert":"_blank","extAlertText":"This website contains links to other federal and state agencies and private organizations. The Department of Health and Human Services (HHS) cannot attest to the accuracy of information provided by these nonfederal website links. Linking to nonfederal sites does not constitute an endorsement by HHS or any of its employees of the sponsors or the information and products presented on the sites. You will be subject to the destination site\u0027s privacy policy when you leave the ASPE website.\r\n\r\nThank you for visiting aspe.hhs.gov!","mailtoClass":0,"mailtoLabel":"(link sends e-mail)"},"stability":{"flickr_id":"52617155@N08","logo_sticky":"28"},"field_group":{"div":"full","hidden":"full"}});
//--><!]]>
</script>
  <script type="text/javascript">
<!--//--><![CDATA[//><!--
var addthis_config={pubid:"ra-5486d15a696bff0c",ui_click:false}
//--><!]]>
</script>


  <script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"bam.nr-data.net","licenseKey":"e4837db659","applicationID":"10708002","transactionName":"MwNaZBRSXEtXB0BdWQpJeVMSWl1WGQpbUFM7FllXA2xEUVMT","queueTime":0,"applicationTime":905,"atts":"H0RZElxIT0U=","errorBeacon":"bam.nr-data.net","agent":""}</script></body>
</html>
